http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 08 Oct 2026 07:30:37 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Insu+Therapeutics+receives+U.S.+patent+allowance+for+buccal+insulin+delivery/27163647.html <p>Insu Therapeutics Inc., a Vancouver-based biotechnology company in which Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) holds a strategic investment, has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application covering its buccal peptide-delivery technology.</p> <p>The allowance relates to U.S. Patent Application No. 18/513,373, titled "Mucoadhesive Pharmaceutical Dosage Form for Unidirectional Release of Peptide Therapeutic Particles." The allowed claims cover the platform's mucoadhesive, layered dosage-form architecture and unidirectional release mechanism for insulin and GLP-1 therapeutics. The published application identifies semaglutide, liraglutide, dulaglutide and exenatide, alongside multiple insulin analogues.</p> <p>The patent allowance supports Insu's two investigational http://www.streetinsider.com/Corporate+News/Insu+Therapeutics+receives+U.S.+patent+allowance+for+buccal+insulin+delivery/27163647.html Thu, 08 Oct 2026 07:30:37 -0400 HYDTF NURS VSQTF VST http://www.streetinsider.com/Corporate+News/Insu+Therapeutics+receives+U.S.+patent+allowance+for+buccal+insulin+delivery/27163647.html <p>Insu Therapeutics Inc., a Vancouver-based biotechnology company in which Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) holds a strategic investment, has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application covering its buccal peptide-delivery technology.</p> <p>The allowance relates to U.S. Patent Application No. 18/513,373, titled "Mucoadhesive Pharmaceutical Dosage Form for Unidirectional Release of Peptide Therapeutic Particles." The allowed claims cover the platform's mucoadhesive, layered dosage-form architecture and unidirectional release mechanism for insulin and GLP-1 therapeutics. The published application identifies semaglutide, liraglutide, dulaglutide and exenatide, alongside multiple insulin analogues.</p> <p>The patent allowance supports Insu's two investigational http://www.streetinsider.com/Corporate+News/Insu+Therapeutics+receives+U.S.+patent+allowance+for+buccal+insulin+delivery/27163647.html Thu, 08 Oct 2026 07:30:37 -0400 HYDTF NURS VSQTF VST http://www.streetinsider.com/Corporate+News/Insu+Therapeutics+receives+U.S.+patent+allowance+for+buccal+insulin+delivery/27163647.html <p>Insu Therapeutics Inc., a Vancouver-based biotechnology company in which Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) holds a strategic investment, has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application covering its buccal peptide-delivery technology.</p> <p>The allowance relates to U.S. Patent Application No. 18/513,373, titled "Mucoadhesive Pharmaceutical Dosage Form for Unidirectional Release of Peptide Therapeutic Particles." The allowed claims cover the platform's mucoadhesive, layered dosage-form architecture and unidirectional release mechanism for insulin and GLP-1 therapeutics. The published application identifies semaglutide, liraglutide, dulaglutide and exenatide, alongside multiple insulin analogues.</p> <p>The patent allowance supports Insu's two investigational http://www.streetinsider.com/Corporate+News/Insu+Therapeutics+receives+U.S.+patent+allowance+for+buccal+insulin+delivery/27163647.html Thu, 08 Oct 2026 07:30:37 -0400 HYDTF NURS VSQTF VST http://www.streetinsider.com/Corporate+News/Insu+Therapeutics+receives+U.S.+patent+allowance+for+buccal+insulin+delivery/27163647.html <p>Insu Therapeutics Inc., a Vancouver-based biotechnology company in which Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) holds a strategic investment, has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application covering its buccal peptide-delivery technology.</p> <p>The allowance relates to U.S. Patent Application No. 18/513,373, titled "Mucoadhesive Pharmaceutical Dosage Form for Unidirectional Release of Peptide Therapeutic Particles." The allowed claims cover the platform's mucoadhesive, layered dosage-form architecture and unidirectional release mechanism for insulin and GLP-1 therapeutics. The published application identifies semaglutide, liraglutide, dulaglutide and exenatide, alongside multiple insulin analogues.</p> <p>The patent allowance supports Insu's two investigational http://www.streetinsider.com/Corporate+News/Insu+Therapeutics+receives+U.S.+patent+allowance+for+buccal+insulin+delivery/27163647.html Thu, 08 Oct 2026 07:30:37 -0400 HYDTF NURS VSQTF VST http://www.streetinsider.com/Press+Releases/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html <div class="xn-content"> <p class="prntal"><i>Milestone advances the technology behind Hydreight's strategic investment and previously announced <location value="LC/us" idsrc="xmltag.org" >U.S</location>. distribution rights</i></p> <p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location> and <location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 8, 2026</chron></span> /PRNewswire/ -- <span value="TorontoVE:NURS" idsrc="xmltag.org" >Hydreight Technologies Inc.</span> ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) today announced that <span>Insu Therapeutics Inc.</span> ("Insu"), in which Hydreight holds a strategic investment, has received http://www.streetinsider.com/Press+Releases/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html Thu, 08 Oct 2026 07:30:00 -0400 HYDTF NURS VSQTF VST http://www.streetinsider.com/PRNewswire/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html <div class="xn-content"> <p class="prntal"><i>Milestone advances the technology behind Hydreight's strategic investment and previously announced <location value="LC/us" idsrc="xmltag.org" >U.S</location>. distribution rights</i></p> <p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location> and <location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 8, 2026</chron></span> /PRNewswire/ -- <span value="TorontoVE:NURS" idsrc="xmltag.org" >Hydreight Technologies Inc.</span> ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) today announced that <span>Insu Therapeutics Inc.</span> ("Insu"), in which Hydreight holds a strategic investment, has received http://www.streetinsider.com/PRNewswire/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html Thu, 08 Oct 2026 07:30:00 -0400 HYDTF NURS VSQTF VST http://www.streetinsider.com/Press+Releases/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html <div class="xn-content"> <p class="prntal"><i>Milestone advances the technology behind Hydreight's strategic investment and previously announced <location value="LC/us" idsrc="xmltag.org" >U.S</location>. distribution rights</i></p> <p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location> and <location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 8, 2026</chron></span> /PRNewswire/ -- <span value="TorontoVE:NURS" idsrc="xmltag.org" >Hydreight Technologies Inc.</span> ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) today announced that <span>Insu Therapeutics Inc.</span> ("Insu"), in which Hydreight holds a strategic investment, has received http://www.streetinsider.com/Press+Releases/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html Thu, 08 Oct 2026 07:30:00 -0400 HYDTF NURS VSQTF VST http://www.streetinsider.com/PRNewswire/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html <div class="xn-content"> <p class="prntal"><i>Milestone advances the technology behind Hydreight's strategic investment and previously announced <location value="LC/us" idsrc="xmltag.org" >U.S</location>. distribution rights</i></p> <p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location> and <location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 8, 2026</chron></span> /PRNewswire/ -- <span value="TorontoVE:NURS" idsrc="xmltag.org" >Hydreight Technologies Inc.</span> ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) today announced that <span>Insu Therapeutics Inc.</span> ("Insu"), in which Hydreight holds a strategic investment, has received http://www.streetinsider.com/PRNewswire/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html Thu, 08 Oct 2026 07:30:00 -0400 HYDTF NURS VSQTF VST http://www.streetinsider.com/Press+Releases/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html <div class="xn-content"> <p class="prntal"><i>Milestone advances the technology behind Hydreight's strategic investment and previously announced <location value="LC/us" idsrc="xmltag.org" >U.S</location>. distribution rights</i></p> <p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location> and <location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 8, 2026</chron></span> /PRNewswire/ -- <span value="TorontoVE:NURS" idsrc="xmltag.org" >Hydreight Technologies Inc.</span> ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) today announced that <span>Insu Therapeutics Inc.</span> ("Insu"), in which Hydreight holds a strategic investment, has received http://www.streetinsider.com/Press+Releases/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html Thu, 08 Oct 2026 07:30:00 -0400 HYDTF NURS VSQTF VST http://www.streetinsider.com/PRNewswire/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html <div class="xn-content"> <p class="prntal"><i>Milestone advances the technology behind Hydreight's strategic investment and previously announced <location value="LC/us" idsrc="xmltag.org" >U.S</location>. distribution rights</i></p> <p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location> and <location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 8, 2026</chron></span> /PRNewswire/ -- <span value="TorontoVE:NURS" idsrc="xmltag.org" >Hydreight Technologies Inc.</span> ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) today announced that <span>Insu Therapeutics Inc.</span> ("Insu"), in which Hydreight holds a strategic investment, has received http://www.streetinsider.com/PRNewswire/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html Thu, 08 Oct 2026 07:30:00 -0400 HYDTF NURS VSQTF VST http://www.streetinsider.com/Press+Releases/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html <div class="xn-content"> <p class="prntal"><i>Milestone advances the technology behind Hydreight's strategic investment and previously announced <location value="LC/us" idsrc="xmltag.org" >U.S</location>. distribution rights</i></p> <p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location> and <location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 8, 2026</chron></span> /PRNewswire/ -- <span value="TorontoVE:NURS" idsrc="xmltag.org" >Hydreight Technologies Inc.</span> ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) today announced that <span>Insu Therapeutics Inc.</span> ("Insu"), in which Hydreight holds a strategic investment, has received http://www.streetinsider.com/Press+Releases/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html Thu, 08 Oct 2026 07:30:00 -0400 HYDTF NURS VSQTF VST http://www.streetinsider.com/PRNewswire/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html <div class="xn-content"> <p class="prntal"><i>Milestone advances the technology behind Hydreight's strategic investment and previously announced <location value="LC/us" idsrc="xmltag.org" >U.S</location>. distribution rights</i></p> <p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location> and <location value="LU/us.nv.lasveg" idsrc="xmltag.org" >LAS VEGAS</location></span>, <span class="legendSpanClass"><chron>Oct. 8, 2026</chron></span> /PRNewswire/ -- <span value="TorontoVE:NURS" idsrc="xmltag.org" >Hydreight Technologies Inc.</span> ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) today announced that <span>Insu Therapeutics Inc.</span> ("Insu"), in which Hydreight holds a strategic investment, has received http://www.streetinsider.com/PRNewswire/Hydreight+Highlights+U.S.+Patent+Allowance+for+Insu+Therapeutics%27+Needle-Free+Insulin+and+GLP-1+Delivery+Technology/27163640.html Thu, 08 Oct 2026 07:30:00 -0400 HYDTF NURS VSQTF VST http://www.streetinsider.com/Press+Releases/Victory+Square+Technologies+Ranks+No.+2+Among+Publicly+Traded+Companies+on+The+Globe+and+Mail%27s+2026+Canada%27s+Top+Growing+Companies+List/27152206.html <div class="xn-content"> <p><b>VST places No. 58 overall with 497% three-year revenue growth; portfolio spans <location value="LC/us" idsrc="xmltag.org" >U.S</location>. healthcare infrastructure, peptide drug delivery and pet health</b></p> <p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>Oct. 6, 2026</chron></span> /PRNewswire/ -- <span value="CNSX:VST" idsrc="xmltag.org" >Victory Square Technologies Inc.</span> ("<span value="CNSX:VST" idsrc="xmltag.org" >Victory Square</span>", "VST" or the "Company") (CSE: VST) (OTCQX: VSQTF) (FWB: 6F6), a publicly traded venture builder, is pleased to announce that http://www.streetinsider.com/Press+Releases/Victory+Square+Technologies+Ranks+No.+2+Among+Publicly+Traded+Companies+on+The+Globe+and+Mail%27s+2026+Canada%27s+Top+Growing+Companies+List/27152206.html Tue, 06 Oct 2026 08:00:00 -0400 NURS VSQTF VST http://www.streetinsider.com/PRNewswire/Victory+Square+Technologies+Ranks+No.+2+Among+Publicly+Traded+Companies+on+The+Globe+and+Mail%27s+2026+Canada%27s+Top+Growing+Companies+List/27152206.html <div class="xn-content"> <p><b>VST places No. 58 overall with 497% three-year revenue growth; portfolio spans <location value="LC/us" idsrc="xmltag.org" >U.S</location>. healthcare infrastructure, peptide drug delivery and pet health</b></p> <p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>Oct. 6, 2026</chron></span> /PRNewswire/ -- <span value="CNSX:VST" idsrc="xmltag.org" >Victory Square Technologies Inc.</span> ("<span value="CNSX:VST" idsrc="xmltag.org" >Victory Square</span>", "VST" or the "Company") (CSE: VST) (OTCQX: VSQTF) (FWB: 6F6), a publicly traded venture builder, is pleased to announce that http://www.streetinsider.com/PRNewswire/Victory+Square+Technologies+Ranks+No.+2+Among+Publicly+Traded+Companies+on+The+Globe+and+Mail%27s+2026+Canada%27s+Top+Growing+Companies+List/27152206.html Tue, 06 Oct 2026 08:00:00 -0400 NURS VSQTF VST http://www.streetinsider.com/Press+Releases/Victory+Square+Technologies+Ranks+No.+2+Among+Publicly+Traded+Companies+on+The+Globe+and+Mail%27s+2026+Canada%27s+Top+Growing+Companies+List/27152206.html <div class="xn-content"> <p><b>VST places No. 58 overall with 497% three-year revenue growth; portfolio spans <location value="LC/us" idsrc="xmltag.org" >U.S</location>. healthcare infrastructure, peptide drug delivery and pet health</b></p> <p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>Oct. 6, 2026</chron></span> /PRNewswire/ -- <span value="CNSX:VST" idsrc="xmltag.org" >Victory Square Technologies Inc.</span> ("<span value="CNSX:VST" idsrc="xmltag.org" >Victory Square</span>", "VST" or the "Company") (CSE: VST) (OTCQX: VSQTF) (FWB: 6F6), a publicly traded venture builder, is pleased to announce that http://www.streetinsider.com/Press+Releases/Victory+Square+Technologies+Ranks+No.+2+Among+Publicly+Traded+Companies+on+The+Globe+and+Mail%27s+2026+Canada%27s+Top+Growing+Companies+List/27152206.html Tue, 06 Oct 2026 08:00:00 -0400 NURS VSQTF VST http://www.streetinsider.com/PRNewswire/Victory+Square+Technologies+Ranks+No.+2+Among+Publicly+Traded+Companies+on+The+Globe+and+Mail%27s+2026+Canada%27s+Top+Growing+Companies+List/27152206.html <div class="xn-content"> <p><b>VST places No. 58 overall with 497% three-year revenue growth; portfolio spans <location value="LC/us" idsrc="xmltag.org" >U.S</location>. healthcare infrastructure, peptide drug delivery and pet health</b></p> <p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>Oct. 6, 2026</chron></span> /PRNewswire/ -- <span value="CNSX:VST" idsrc="xmltag.org" >Victory Square Technologies Inc.</span> ("<span value="CNSX:VST" idsrc="xmltag.org" >Victory Square</span>", "VST" or the "Company") (CSE: VST) (OTCQX: VSQTF) (FWB: 6F6), a publicly traded venture builder, is pleased to announce that http://www.streetinsider.com/PRNewswire/Victory+Square+Technologies+Ranks+No.+2+Among+Publicly+Traded+Companies+on+The+Globe+and+Mail%27s+2026+Canada%27s+Top+Growing+Companies+List/27152206.html Tue, 06 Oct 2026 08:00:00 -0400 NURS VSQTF VST http://www.streetinsider.com/Press+Releases/Victory+Square+Technologies+Ranks+No.+2+Among+Publicly+Traded+Companies+on+The+Globe+and+Mail%27s+2026+Canada%27s+Top+Growing+Companies+List/27152206.html <div class="xn-content"> <p><b>VST places No. 58 overall with 497% three-year revenue growth; portfolio spans <location value="LC/us" idsrc="xmltag.org" >U.S</location>. healthcare infrastructure, peptide drug delivery and pet health</b></p> <p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>Oct. 6, 2026</chron></span> /PRNewswire/ -- <span value="CNSX:VST" idsrc="xmltag.org" >Victory Square Technologies Inc.</span> ("<span value="CNSX:VST" idsrc="xmltag.org" >Victory Square</span>", "VST" or the "Company") (CSE: VST) (OTCQX: VSQTF) (FWB: 6F6), a publicly traded venture builder, is pleased to announce that http://www.streetinsider.com/Press+Releases/Victory+Square+Technologies+Ranks+No.+2+Among+Publicly+Traded+Companies+on+The+Globe+and+Mail%27s+2026+Canada%27s+Top+Growing+Companies+List/27152206.html Tue, 06 Oct 2026 08:00:00 -0400 NURS VSQTF VST http://www.streetinsider.com/PRNewswire/Victory+Square+Technologies+Ranks+No.+2+Among+Publicly+Traded+Companies+on+The+Globe+and+Mail%27s+2026+Canada%27s+Top+Growing+Companies+List/27152206.html <div class="xn-content"> <p><b>VST places No. 58 overall with 497% three-year revenue growth; portfolio spans <location value="LC/us" idsrc="xmltag.org" >U.S</location>. healthcare infrastructure, peptide drug delivery and pet health</b></p> <p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>Oct. 6, 2026</chron></span> /PRNewswire/ -- <span value="CNSX:VST" idsrc="xmltag.org" >Victory Square Technologies Inc.</span> ("<span value="CNSX:VST" idsrc="xmltag.org" >Victory Square</span>", "VST" or the "Company") (CSE: VST) (OTCQX: VSQTF) (FWB: 6F6), a publicly traded venture builder, is pleased to announce that http://www.streetinsider.com/PRNewswire/Victory+Square+Technologies+Ranks+No.+2+Among+Publicly+Traded+Companies+on+The+Globe+and+Mail%27s+2026+Canada%27s+Top+Growing+Companies+List/27152206.html Tue, 06 Oct 2026 08:00:00 -0400 NURS VSQTF VST http://www.streetinsider.com/Press+Releases/Victory+Square+Technologies+Reports+First-Half+2026+Revenue+of+%2453.0+Million+and+Net+Income+of+%246.5+Million/27010068.html <div class="xn-content"> <p><i>Q2 revenue increases 421% year-over-year to <money>$28.0 million</money>; cash reaches <money>$20.2 million</money> and working capital increases to <money>$34.5 million</money> </i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>Sept. 1, 2026</chron></span> /PRNewswire/ -- <b><span value="CNSX:VST" idsrc="xmltag.org" >Victory Square Technologies Inc.</span> ("<span value="CNSX:VST" idsrc="xmltag.org" >Victory Square</span>", "VST" or the "Company") </b>(CSE: VST) (OTCQX: VSQTF) (FWB: 6F6), a venture builder focused on healthcare infrastructure, digital health, artificial intelligence and emerging technology platforms, today announced its financial results for the three and six months ended <chron>June 30, 2026</chron>, and provided an update on key portfolio developments.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Victory+Square+Technologies+Reports+First-Half+2026+Revenue+of+%2453.0+Million+and+Net+Income+of+%246.5+Million/27010068.html Tue, 01 Sep 2026 09:11:00 -0400 NURS VST http://www.streetinsider.com/PRNewswire/Victory+Square+Technologies+Reports+First-Half+2026+Revenue+of+%2453.0+Million+and+Net+Income+of+%246.5+Million/27010068.html <div class="xn-content"> <p><i>Q2 revenue increases 421% year-over-year to <money>$28.0 million</money>; cash reaches <money>$20.2 million</money> and working capital increases to <money>$34.5 million</money> </i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>Sept. 1, 2026</chron></span> /PRNewswire/ -- <b><span value="CNSX:VST" idsrc="xmltag.org" >Victory Square Technologies Inc.</span> ("<span value="CNSX:VST" idsrc="xmltag.org" >Victory Square</span>", "VST" or the "Company") </b>(CSE: VST) (OTCQX: VSQTF) (FWB: 6F6), a venture builder focused on healthcare infrastructure, digital health, artificial intelligence and emerging technology platforms, today announced its financial results for the three and six months ended <chron>June 30, 2026</chron>, and provided an update on key portfolio developments.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Victory+Square+Technologies+Reports+First-Half+2026+Revenue+of+%2453.0+Million+and+Net+Income+of+%246.5+Million/27010068.html Tue, 01 Sep 2026 09:11:00 -0400 NURS VST http://www.streetinsider.com/Press+Releases/Victory+Square+Technologies+Reports+First-Half+2026+Revenue+of+%2453.0+Million+and+Net+Income+of+%246.5+Million/27010068.html <div class="xn-content"> <p><i>Q2 revenue increases 421% year-over-year to <money>$28.0 million</money>; cash reaches <money>$20.2 million</money> and working capital increases to <money>$34.5 million</money> </i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>Sept. 1, 2026</chron></span> /PRNewswire/ -- <b><span value="CNSX:VST" idsrc="xmltag.org" >Victory Square Technologies Inc.</span> ("<span value="CNSX:VST" idsrc="xmltag.org" >Victory Square</span>", "VST" or the "Company") </b>(CSE: VST) (OTCQX: VSQTF) (FWB: 6F6), a venture builder focused on healthcare infrastructure, digital health, artificial intelligence and emerging technology platforms, today announced its financial results for the three and six months ended <chron>June 30, 2026</chron>, and provided an update on key portfolio developments.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Victory+Square+Technologies+Reports+First-Half+2026+Revenue+of+%2453.0+Million+and+Net+Income+of+%246.5+Million/27010068.html Tue, 01 Sep 2026 09:11:00 -0400 NURS VST http://www.streetinsider.com/PRNewswire/Victory+Square+Technologies+Reports+First-Half+2026+Revenue+of+%2453.0+Million+and+Net+Income+of+%246.5+Million/27010068.html <div class="xn-content"> <p><i>Q2 revenue increases 421% year-over-year to <money>$28.0 million</money>; cash reaches <money>$20.2 million</money> and working capital increases to <money>$34.5 million</money> </i></p><p><span class="legendSpanClass"><location value="LU/ca.bc.vancvr" idsrc="xmltag.org" >VANCOUVER, BC</location></span>, <span class="legendSpanClass"><chron>Sept. 1, 2026</chron></span> /PRNewswire/ -- <b><span value="CNSX:VST" idsrc="xmltag.org" >Victory Square Technologies Inc.</span> ("<span value="CNSX:VST" idsrc="xmltag.org" >Victory Square</span>", "VST" or the "Company") </b>(CSE: VST) (OTCQX: VSQTF) (FWB: 6F6), a venture builder focused on healthcare infrastructure, digital health, artificial intelligence and emerging technology platforms, today announced its financial results for the three and six months ended <chron>June 30, 2026</chron>, and provided an update on key portfolio developments.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Victory+Square+Technologies+Reports+First-Half+2026+Revenue+of+%2453.0+Million+and+Net+Income+of+%246.5+Million/27010068.html Tue, 01 Sep 2026 09:11:00 -0400 NURS VST http://www.streetinsider.com/Press+Releases/Hydreight+Reports+Record+Q2+2026+Revenue+of+%2428.0+Million%2C+Net+Income+of+%242.5+Million+and+Adjusted+EBITDA+of+%243.2+Million/27007312.html <div class="xn-content"> <p><b>Revenue increased 421% year-over-year as Hydreight delivered its strongest revenue quarter to date, with continued sequential growth in revenue and gross profit while maintaining strong profitability </b></p><p><b>Q2 2026 Highlights</b></p><ul type="disc"><li><b>Revenue of <money>$28.0 million</money></b>, an increase of <b>421%</b> from <money>$5.4 million</money> in Q2 2025 and approximately <b>12.5%</b> from Q1 2026</li><li><b>Gross profit of <money>$5.4 million</money></b>, an increase of <b>182% from <money>$1.9 million</money> in Q2 2025</b> and approximately <b>7% quarter over quarter</b></li><li><b>Net income of <money>$2.5 million</money></b>, compared with <money>$0.05 million</money> in Q2 2025</li><li><b>Adjusted EBITDA¹ of <money>$3.2 million</money></b>, compared with <money>$0.2 million</money> in Q2 2025</li><li><b>Six-month revenue of <money>$53.0 million</money></b>, an increase of <b>434% year-over-year</b></li><li><b>Six-month net income http://www.streetinsider.com/Press+Releases/Hydreight+Reports+Record+Q2+2026+Revenue+of+%2428.0+Million%2C+Net+Income+of+%242.5+Million+and+Adjusted+EBITDA+of+%243.2+Million/27007312.html Mon, 31 Aug 2026 22:25:00 -0400 NURS VST http://www.streetinsider.com/PRNewswire/Hydreight+Reports+Record+Q2+2026+Revenue+of+%2428.0+Million%2C+Net+Income+of+%242.5+Million+and+Adjusted+EBITDA+of+%243.2+Million/27007312.html <div class="xn-content"> <p><b>Revenue increased 421% year-over-year as Hydreight delivered its strongest revenue quarter to date, with continued sequential growth in revenue and gross profit while maintaining strong profitability </b></p><p><b>Q2 2026 Highlights</b></p><ul type="disc"><li><b>Revenue of <money>$28.0 million</money></b>, an increase of <b>421%</b> from <money>$5.4 million</money> in Q2 2025 and approximately <b>12.5%</b> from Q1 2026</li><li><b>Gross profit of <money>$5.4 million</money></b>, an increase of <b>182% from <money>$1.9 million</money> in Q2 2025</b> and approximately <b>7% quarter over quarter</b></li><li><b>Net income of <money>$2.5 million</money></b>, compared with <money>$0.05 million</money> in Q2 2025</li><li><b>Adjusted EBITDA¹ of <money>$3.2 million</money></b>, compared with <money>$0.2 million</money> in Q2 2025</li><li><b>Six-month revenue of <money>$53.0 million</money></b>, an increase of <b>434% year-over-year</b></li><li><b>Six-month net income http://www.streetinsider.com/PRNewswire/Hydreight+Reports+Record+Q2+2026+Revenue+of+%2428.0+Million%2C+Net+Income+of+%242.5+Million+and+Adjusted+EBITDA+of+%243.2+Million/27007312.html Mon, 31 Aug 2026 22:25:00 -0400 NURS VST http://www.streetinsider.com/Press+Releases/Hydreight+Reports+Record+Q2+2026+Revenue+of+%2428.0+Million%2C+Net+Income+of+%242.5+Million+and+Adjusted+EBITDA+of+%243.2+Million/27007312.html <div class="xn-content"> <p><b>Revenue increased 421% year-over-year as Hydreight delivered its strongest revenue quarter to date, with continued sequential growth in revenue and gross profit while maintaining strong profitability </b></p><p><b>Q2 2026 Highlights</b></p><ul type="disc"><li><b>Revenue of <money>$28.0 million</money></b>, an increase of <b>421%</b> from <money>$5.4 million</money> in Q2 2025 and approximately <b>12.5%</b> from Q1 2026</li><li><b>Gross profit of <money>$5.4 million</money></b>, an increase of <b>182% from <money>$1.9 million</money> in Q2 2025</b> and approximately <b>7% quarter over quarter</b></li><li><b>Net income of <money>$2.5 million</money></b>, compared with <money>$0.05 million</money> in Q2 2025</li><li><b>Adjusted EBITDA¹ of <money>$3.2 million</money></b>, compared with <money>$0.2 million</money> in Q2 2025</li><li><b>Six-month revenue of <money>$53.0 million</money></b>, an increase of <b>434% year-over-year</b></li><li><b>Six-month net income http://www.streetinsider.com/Press+Releases/Hydreight+Reports+Record+Q2+2026+Revenue+of+%2428.0+Million%2C+Net+Income+of+%242.5+Million+and+Adjusted+EBITDA+of+%243.2+Million/27007312.html Mon, 31 Aug 2026 22:25:00 -0400 NURS VST